KLOW Blend (BPC-157 + GHK-Cu + TB-500 + KPV)

KLOW Blend (BPC-157 + GHK-Cu + TB-500 + KPV)

KLOW Blend is a co-blended research combination of four synthetic peptides: BPC-157, a pentadecapeptide studied for tissue-repair and cytoprotective activity; GHK-Cu, a copper-chelated tripeptide studied for connective-tissue and matrix-remodeling activity; TB-500, the full-length Thymosin Beta-4 peptide studied for actin-binding and cytoskeletal activity; and KPV, a tripeptide fragment of alpha-MSH studied for anti-inflammatory NF-κB pathway activity.

This blend is studied in preclinical research settings for molecular interactions spanning nitric-oxide signaling, copper-dependent matrix remodeling, cytoskeletal/cell-migration pathways, and inflammatory-signaling suppression. It is supplied at a nominal 10mg + 50mg + 10mg + 10mg fill (80mg total per vial).

RESEARCH USE ONLY: This product is intended for laboratory research purposes only. We do not sell this product for human or animal consumption.

Chemical and Molecular Properties

BPC-157

GHK-Cu

TB-500

KPV

Note: “TB-500” sometimes refers in the literature to a shorter 7-amino-acid fragment (CAS 885340-08-9); the properties above describe the full-length sequence commonly supplied under the TB-500 name in the research-peptide trade. KPV does not bind melanocortin receptors and has no pigmentation-related activity, despite being derived from the alpha-MSH sequence.

Proposed Working Mechanism of KLOW Blend

Investigational findings indicate that BPC-157 may interact with the nitric oxide (NO) signaling pathway. In preclinical research models, this interaction has been associated with cytoprotective and pro-angiogenic activity relevant to tissue and gastrointestinal repair research.

Research data suggests GHK-Cu’s potential to stimulate collagen, elastin, and glycosaminoglycan synthesis through copper-dependent extracellular-matrix remodeling, while TB-500 is studied for its interaction with monomeric actin (G-actin), a mechanism of particular investigational interest in cell-migration and cytoskeletal-signaling research.

Studies conducted in controlled laboratory environments have observed that KPV may inhibit NF-κB signaling, a pathway associated with pro-inflammatory cytokine production. This interaction is of particular investigational interest in the context of inflammatory-response research, layered alongside the three tissue-repair mechanisms above.

Note: KLOW Blend is an investigational compound. It is not approved for clinical use; all mechanistic data are derived exclusively from studies of the individual active components administered separately, not from testing of this specific four-peptide co-blended formulation.

Possible Research Applications of KLOW Blend

This blend combines four synthetic peptides that have gained attention in tissue-repair and inflammation research for their potential research applications, which include:

Tissue Repair & Cytoprotective Research Preclinical investigations in laboratory models have recorded measurable shifts in tissue and gastrointestinal mucosal integrity metrics, with nitric-oxide-pathway activity documented as a key parameter.

Connective Tissue & Matrix Remodeling Research Investigational studies have yielded quantifiable data on collagen, elastin, and glycosaminoglycan synthesis markers in copper-dependent matrix-remodeling research settings.

Cytoskeletal & Cell-Migration Research Investigational findings have documented modulation of G-actin interaction and cell-migration signaling relevant to cytoskeletal research models.

Anti-Inflammatory Pathway Research Preclinical studies have recorded notable shifts in NF-κB signaling activity and pro-inflammatory cytokine markers linked to KPV research, relevant to combination anti-inflammatory and repair-pathway research frameworks.

Research Stability & Handling Profile

KLOW Blend exhibits notable stability characteristics that distinguish it within the peptide research space.

Storage Recommendations for Research Use:

• Store lyophilized KLOW Blend at -20°C or lower in a sealed, desiccated environment
• Once reconstituted for laboratory use, maintain at 2–8°C and utilize within established research protocol timeframes
• Avoid repeated freeze-thaw cycles to preserve peptide integrity for research purposes
• Keep away from UV light exposure during storage
• For reconstitution, use sterile bacteriostatic water. Do not use saline.

Risk & Handling

• KLOW Blend is intended for research purposes only and should be handled by trained professionals using appropriate laboratory procedures and safety protocols.
• Due to limited clinical data on this specific four-peptide combination, the full safety profile, potential adverse effects, and long-term implications remain under investigation.
• Researchers should avoid direct exposure through inhalation, ingestion, or skin contact and use suitable protective equipment (gloves, respirator, eye protection) during handling.
• Materials should be stored in a cool, dry, and controlled environment away from heat, moisture, and direct sunlight to maintain stability and integrity.
• All preparation and handling equipment should be sterile and properly maintained to reduce the risk of contamination or compromised results.
• KLOW Blend should not be marketed or represented as an approved treatment, cure, or preventive solution for any medical condition without regulatory authorization.
• Proper documentation, labeling, and disposal procedures should be followed in accordance with institutional, local, and national regulations.
• Individuals with underlying medical conditions, those taking medications, or anyone considering experimental applications should seek guidance from qualified healthcare or research professionals.
• TB-500 is prohibited at all times under the WADA Prohibited List (S2.3, Growth Factors); tested athletes should not handle or use this product. BPC-157 is additionally listed under WADA Section S0 (Non-Approved Substances) as a pharmacological substance not approved for human therapeutic use by any regulatory authority. Tested athletes should not handle or use this product.

PureRawz Quality & Purity Standards

PureRawz is committed to supplying the USA research community with the highest-integrity investigational compounds available. Every batch of KLOW Blend is confirmed by independent third-party HPLC analysis, with a Certificate of Analysis (COA) available per lot.

Note: KLOW Blend is an investigational compound and has not been established as safe or effective for any therapeutic use in this specific co-blended form.

Frequently Asked Questions

Is it legal to buy KLOW Blend in the US? 

Yes. It’s sold as a research chemical, not a drug, so ordering it for lab use is legal.

Do I need any kind of permit to order this? 

No permit is needed to buy it, but only trained lab people should actually handle or use it.

How many peptides are in one vial? 

Four  BPC-157, GHK-Cu, TB-500, and KPV  mixed together, totaling 80mg.

Has this exact four-peptide mix been tested together? 

No. Each one has its own research on its own, but not this specific combo as one product.

What’s this blend generally used for in research? 

Mostly tissue repair and calming inflammation each peptide covers a different piece, from protecting tissue to rebuilding connective tissue to helping cells move to reducing inflammatory signals.

How should I store this once it shows up? 

Keep it frozen at -20°C, away from light. Once mixed with water, put it in the fridge and use it soon.

Is this safe to work with? 

It hasn’t been fully tested for safety as a four-peptide combo, so treat it carefully and follow lab safety steps.

Can athletes use TB-500 without an issue? 

No. TB-500 is banned by name on the World Anti-Doping Agency’s list, no exceptions.

Disclaimer

This information is for educational purposes only and not medical advice. Products are for research use only. Research must follow IRB or IACUC guidelines. Verify information independently before purchasing. By ordering, you agree to our Terms and Conditions. If you are not 100% satisfied with the product you received, please contact us at support@purerawz.co.

ATTENTION: All our products are for LABORATORY AND RESEARCH PURPOSES ONLY, not for veterinary or human use.

Reference Links

• Sikiric, P., Seiwerth, S., Rucman, R., et al. (2014). Stable gastric pentadecapeptide BPC 157-NO-system relation. Current Pharmaceutical Design, 20(7), 1126–1135. PMID: 23755725. https://pubmed.ncbi.nlm.nih.gov/23755725/
• Pickart, L., & Margolina, A. (2018). Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. International Journal of Molecular Sciences, 19(7), 1987. PMID: 29986520. https://pubmed.ncbi.nlm.nih.gov/29986520/
• Goldstein, A. L., Hannappel, E., Sosne, G., & Kleinman, H. K. (2012). Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opinion on Biological Therapy, 12(1), 37–51. PMID: 22074294. https://pubmed.ncbi.nlm.nih.gov/22074294/
• Dalmasso, G., Charrier-Hisamuddin, L., Nguyen, H. T., Yan, Y., Sitaraman, S., & Merlin, D. (2008). PepT1-mediated tripeptide KPV uptake reduces intestinal inflammation. Gastroenterology, 134(1), 166–178. PMID: 18061177. https://pubmed.ncbi.nlm.nih.gov/18061177/